Inactive Instrument

Analyst Reco. Celyad Oncology SA OTC Markets

Equities

HC Wainwright Downgrades Celyad Oncology Neutral From Buy, Shares Plunge 12% at Midday Trading	28/22/28	MT
Wells Fargo Adjusts Celyad Oncology's Price Target to $11 from $20, Keeps Overweight Rating	11/22/11	MT
Wall Street Set for Narrow Gains, US Unemployment Rate Falls in November	03/21/03	MT
CELYAD ONCOLOGY : HC Wainwright Adjusts Celyad Oncology's Price Target to $15 From $17, Maintains Buy Rating	06/21/06	MT
CELYAD ONCOLOGY : JonesTrading Downgrades Celyad Oncology to Hold from Buy	26/21/26	MT
CELYAD ONCOLOGY : HC Wainwright Adjusts Celyad Oncology's Price Target to $18 From $22, Keeps Buy Rating	08/20/08	MT

No results for this search